Day: July 23, 2025

Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the aflibercept arm Study Enrolled Treatment-Naïve, or Almost Naïve, Patients with DME Results presented by Michael A. Singer, M.D. in a paper-on-demand presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting Conference call scheduled for today at 8:30 am ET PRINCETON, N.J., July 23, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced results from the NEW DAY clinical trial of ILUVIEN® (fluocinolone acetonide intravitreal implant), 0.19 mg (ILUVIEN) for use in patients with diabetic macular edema (DME). The results were presented in a paper-on-demand presentation by Michael A. Singer, M.D., Clinical Professor of Ophthalmology at University...

Seasoned Retail and Consumer Brand Leaders Pamela Edwards and Jerome Griffith Join Board of Directors NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or the “Company”) appointed Jerome Griffith to the Company’s Board of Directors (the “Board”), effective July 20, 2025, joining Pamela Edwards, who was appointed to the Board effective March 20, 2025. Ms. Edwards is a highly experienced financial leader, having served as a Chief Financial Officer for several large specialty retailers and consumer brands. Most recently, Ms. Edwards served as the Chief Financial Officer and Executive Vice President of Citi Trends, Inc., a publicly held, leading specialty value store with a rich history of bringing fashionable products across categories from fashion and accessories to...

SHELTON, Conn., July 23, 2025 (GLOBE NEWSWIRE) — Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended June 30, 2025 were $54.0 million compared to $55.4 million in the second quarter of 2024, a decrease of 3%. Net sales for the six months ended June 30, 2025 were $100.0 million, compared to $100.4 million in the same period in 2024. Net income was $4.8 million, or $1.16 per diluted share, for the quarter ended June 30, 2025, compared to $4.5 million, or $1.09 per diluted share, for the same period in 2024, an increase of 7% in net income and 6% in diluted earnings per share. Net income for the six months ended June 30, 2025 was $6.4 million, or $1.57 per diluted share, compared to $6.1 million, or $1.47 per diluted share, for the same period in 2024, an increase of 5% in net income and...

TORONTO, July 23, 2025 (GLOBE NEWSWIRE) — McEwen Inc. (NYSE: MUX) (TSX: MUX) (“McEwen”, “MUX” or the “Company”) is pleased to announce the discovery of high-grade mineralization approximately 200 meters West of the Froome Mine, which is the current source of production at the Fox Complex. This discovery will extend our mining at Froome. Highlights from Drilling at Froome West: Intercepts along the Froome West high-grade plunge (refer to Figures 2 and 3):Hole 25PR-G424 returned 36.0 g/t gold over 10.0 m (including 160.0 g/t gold over 2.2 m), and 9.3 g/t gold over 7.8 m. Hole 25PR-G399 returned 6.7 g/t gold over 3.4 m. Hole 25PR-G381 returned 15.0 g/t gold over 6.6 m and 4.9 g/t gold over 2.2 m.Extending mineralization further West (refer to Figures 2 and 3):Hole 25PR-G390 returned 11.7 g/t gold over 2.4 m...

CHICO, Calif., July 23, 2025 (GLOBE NEWSWIRE) — Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU), the attainable luxury brand for women, announced today that the Company will release its second quarter 2025 financial results on Wednesday, August 13, 2025, after market close. The Company will host a conference call and live webcast with the investment community at 5:00 p.m. Eastern Time that same day. The financial results and live webcast will be accessible through the Investor Relations section of the Company’s website at https://investors.lulus.com/. To access the call through a conference line, dial 1-877-407-0792 (in the U.S.) or 1-201-689-8263 (international callers). A replay of the conference call will be posted shortly after the call and will be available for seven days. To access the...

GRAND FALLS-WINDSOR, Newfoundland and Labrador, July 23, 2025 (GLOBE NEWSWIRE) — First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) (“First Atlantic” or the “Company”) is pleased to announce the release of its Initial Phase 2 Drill Plan Map detailing the locations of the first five holes at the RPM Zone, within its 100%-owned Atlantic Nickel Project in central Newfoundland. The recently completed Phase 1 drilling program successfully defined a near-surface mineralized zone measuring approximately 400m x 500m containing magnetically recoverable awaruite nickel mineralization. All Phase 1 RPM Zone drill holes intersected broad, continuous zones of mineralization, yielding consistent grades and recoveries. Metallurgical testing via the Davis Tube Recovery (DTR) method yielded an average magnetically...

Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. Tranche 1 of the private placement amounted to 4,731,594 shares. As disclosed separately, Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, participated in the private placement and subscribed for 739,360 shares in Tranche 1. In connection with the private placement, the manager of the private placement, IDEX Biometrics and Mr. Storbråten entered into a share lending agreement. Mr. Storbråten has lent 4,731,594 shares, ISIN NO0013536078, in connection with the settlement of Tranche 1. The shares have been lent, not sold, and will be returned in due course.  After the subscription by...

Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders.  In tranche 1 of the private placement, total 4,731,594 shares :- Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 739,360 shares, ISIN NO0013536078, at NOK 3.30 per share, andK-konsult AS, a company closely related to chair Morten Opstad, subscribed to 128,156 shares, ISIN NO0013536078, at NOK 3.30 per share. Contact personAnders Storbråten, CEO and CFO Tel: +47 4163 8582E-mail: ir@idexbiometrics.com About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control,...

On 22 July 2025, Fitch Ratings has assigned Eesti Energia AS first-time long-term issuer default rating BBB- with stable outlook. This is the first time Fitch has assigned a credit rating to Eesti Energia. Details on the publication can be found here: https://www.enefit.com/en/ettevottest/investorile Further Information: Danel FreibergHead of Treasury and Financial Risk ManagementEesti Energia ASTel: +372 5594 3838Email: danel.freiberg@energia.ee